For example, the prevalence of pain is estimated to be 55% during anticancer treatment; 39% after curative treatment; 66% in advanced, metastatic, or terminal disease; and 50.7% in all cancer stages. 30 The prevalence of fatigue is estimated to be 14-27% among breast cancer survivors, 78% among older patients receiving palliative care, and 7% ....